We are MLL.
Corporate movie
1284998
Samples received since 2005
370
Employees
819
Publications
9114
Square meters laboratory space
Our expertise
- Comprehensive diagnostics of leukemias and lymphomas from a single provider, combining information from the various diagnostic areas and summarizing it in integrated reports
- Digitally controlled data evaluation using state-of-the-art software and algorithms including artificial intelligence (AI) methods
- Error prevention through automation and the digitalization of laboratory processes
Our methods
United within a single facility, our interdisciplinary structure guarantees valid, comprehensive and prompt diagnosis thanks to a steady flow of information between the departments. In this context, we work with more than 900 devices and have 993 standard operating procedures (SOP).
The laboratory
The Munich Leukemia Laboratory (MLL) is one of the world's largest leukemia labs. Boasting state-of-art equipment and a bright and functional facility layout, MLL meets all the requirements of an innovative and modern workplace. With its adherence to the principles of consummate curiosity and its dedication to progress, the new-look MLL nevertheless remains true to its goal of facilitating access to targeted, efficient and timely therapy to patients worldwide.
Our culture
Our mission
The focus of our work is the responsibility for patients with hematological neoplasms.
Our contribution is to provide comprehensive and personalized diagnostics with the shortest possible turnaround time.
The results of these diagnostics enable precise, individualized therapy with additional treatment options and improved chances of cure.
Our vision
We set standards in the diagnosis of hematological neoplasms through our own research and integration of global knowledge. To achieve this, we rely on our expertise, innovation and interdisciplinarity.
We are shaping the future of hematological diagnostics with state-of-the-art methods.
We are constantly working to further improve the chances of cure for hematologic neoplasms and are developing prevention concepts for this purpose.
Our values
We believe that extraordinary things emerge by blending knowledge, courage and responsibility.
In a world of constantly evolving, groundbreaking opportunities, our aim is to offer the best leukemia diagnostics at global level and to make it available to all patients.
The team
We seek to comprehend what is not yet fully understood: how leukemia emerges, its interdependencies and complexity. As a large, interdisciplinary team of experienced doctors, biologists, bioinformatics specialists and medical technicians, we work to provide patients worldwide with more targeted and efficient treatments as quickly as possible. Our deployment of state-of-the-art methods and devices, continuous communication of test results between the various departments, as well as constant further training, ensure the speed and reliability of our diagnoses. Consistent sharing of test results and the steady expansion of staff knowledge guarantee reliable diagnostics. The team of excellently qualified staff members is therefore the nerve center at MLL.
Our management
Before cofounding MLL in 2005, Prof. Dr. Dr. Haferlach was a senior physician at various large university clinics with habilitation in internal medicine and a specialization in hematology and internal oncology
Prof. Dr. med. Dr. phil. Torsten Haferlach
Executive management
Internist, Hematologist and Oncologist
torsten.haferlach@mll.com
Prof. Dr. med. Wolfgang Kern was head of the immunophenotyping section in the Laboratory for Special Leukemia Diagnostics at the Clinic München-Großhadern. Since he founded the MLL Munich Leukemia Laboratory and the MHP Munich Hematology Practice in 2005, he served as head of this division. In 2023, he relinquished divisional leadership and now serves as deputy head.
Prof. Dr. med. Wolfgang Kern
Executive Management
Internist, Hematologist and Oncologist
Head of business unit Finance
Head of business unit Strategy & Business Development
wolfgang.kern@mll.com
Personal contact
Dr. med. Christian Dornes
Head of business unit MLL MVZ
Internist, Hematologist and Oncologist
Head of MLL MVZ
christian.dornes@mll.com
Dr. med. Katrin Schweneker
Internist, Hematologist and Oncologist
Deputy Head of MLL MVZ
katrin.schweneker@mll.com
Dr. rer. nat. Manja Meggendorfer, MBA
Biologist, Dipl.
Head of business unit Diagnostic Genetics
Head of Molecular genetics
Head of Research
manja.meggendorfer@mll.com
Dr. rer. nat. Isolde Summerer
Biologist, Dipl.
Head of Cytogenetics
Deputy Head of Chromosome analysis diagnostics
Deputy Head of FISH diagnostics
isolde.summerer@mll.com
Marietta Truger
Deputy Head of Cytogenetics
Head of FISH Diagnostics
marietta.truger@mll.com
Dr. med. vet. Verena Mühlbacher
Veterinarian
Head of Chromosome analysis laboratory
verena.muehlbacher@mll.com
Dr. rer. nat. Bettina Balk
Molecular Medicine
Head of FISH laboratory
bettina.balk@mll.com
Dr. rer nat. Janine Müller
Biologist, M.Sc.
Head of Chromosome analysis diagnostics
janine.mueller@mll.com
Dr. rer. nat. Annabell Deuchert
Biologist, Dipl.
Deputy Head of Chromosome analysis laboratory
annabell.deuchert@mll.com
Melanie Zenger
Biomedical Scientist, M.Sc.
Deputy Head of FISH laboratory
melanie.zenger@mll.com
Dr. rer. nat. Manja Meggendorfer, MBA
Biologist, Dipl.
Head of business unit Diagnostic Genetics
Head of Molecular genetics
Head of Research
manja.meggendorfer@mll.com
Dr. rer. nat. Christiane Eder
Biologist, Dipl.
Deputy Head of Molecular genetics
Head of Cell / nucleic acid processing
christiane.eder@mll.com
Dr. rer. nat. Frank Dicker
Biologist, Dipl.
Head of Diagnostic Reporting Molecular genetics
frank.dicker@mll.com
Dr. rer. nat. Sandra Weißmann
Biologist, Dipl.
Head of PCR/Fragment Analysis
Deputy Head of Diagnostic reporting
sandra.weissmann@mll.com
Dr. rer. nat. Henning Ruge
Biochemist, M.Sc.
Deputy Head of Sequencing
henning.ruge@mll.com
Dr. rer. physiol. Sylvia Möckel
Biologist, Dipl.
Deputy Head of PCR / Fragment Analysis
sylvia.moeckel@mll.com
Nicole Schlenther
Deputy Head of Cell and nucleic acid processing
nicole.schlenther@mll.com
PD Dr. med. Gregor Hörmann, PhD
Laboratory Medicine
Head of business unit Diagnostic Phenotype
Head of Sample Receipt
gregor.hoermann@mll.com
Dr. med. Christian Pohlkamp
Internist, Hematologist and Oncologist
Head of business unit Diagnostic Knowledge & AI
Head of Cytomorphology
Head of Customer Care
christian.pohlkamp@mll.com
Dr. med. univ. Christoph Kornauth
Pathologist
Deputy Head of Cytomorphology
christoph.kornauth@mll.com
Dr. rer. nat. Christopher Maier
Biologist, M.Sc.
Deputy Head of Cytomorphology
christopher.maier@mll.com
Martha-Lena Müller, Ph.D.
Molecular biologist, M.Sc.
Head of Immunophenotpying
Head of Diagnostic Reporting Immunophenotyping
martha-lena.mueller@mll.com
Dr. rer. nat. Veronika Ecker
Molecular medicine, M.Sc.
Deputy Head of Immunophenotpying
Head of Technology & Development Immunophenotyping
veronika.ecker@mll.com
Dr. med. Chrysanthi Tsamadou
Laboratory Medicine
Immunogenetist
Head of Immunophenotyping laboratory
chrysanthi.tsamadou@mll.com
Dr. Dr. med. Armin Piehler, PhD MM
Head of Classical Hematology
armin.piehler@mll.com
PD Dr. med. Gregor Hörmann, PhD
Laboratory Medicine
Head of business unit Diagnostic Phenotype
Head of Sample Receipt
gregor.hoermann@mll.com
Antje Müller
Deputy Head of Sample Receipt
Biologist, M.Sc.
antje.mueller@mll.com
Dr. med. Christian Pohlkamp
Internist, Hematologist and Oncologist
Head of business unit Diagnostic Knowledge & AI
Head of Cytomorphology
Head of Customer Care
christian.pohlkamp@mll.com
Julia Hennig
Head of Customer support
Client communication
julia.hennig@mll.com
PD Dr. med. Gregor Hörmann, PhD
Laboratory Medicine
Head of business unit Diagnostic Phenotype
Head of Sample Receipt
Head of Order Control
gregor.hoermann@mll.com
Dr. med. Adriane Koppelle
Internist, Hematologist and Oncologist
Deputy Head of Order Control
adriane.koppelle@mll.com
Prof. Dr. med. Wolfgang Kern
Executive Management
Internist, Hematologist and Oncologist
Head of business unit Finance
Head of business unit Strategy & Business Development
wolfgang.kern@mll.com
Roman Möhlmann
Head of Communications & Marketing
Media & press contact
presse@mll.com
Dr. rer. nat. Anna Stengel
Biochemist, M.Sc.
Head of Med. Data & Study Management
anna.stengel@mll.com
Dr. sc. Alessandro Baldi
Head of Research Department
alessandro.baldi@mll.com
Dr. Wencke Walter
Bioinformatician, M.Sc.
Head of Innovation Department
wencke.walter@mll.com
Martin Bucher
Head of business unit IT
Platform Development & IT Infrastructure
martin.bucher@mll.com
Dr. rer. nat. Björn Peters
Molecular biotechnologist, M.Sc.
Head of Application development
bjoern.peters@mll.com
Ralf Fritzsche
Computer scientist
Deputy Head of Application Development
ralf.fritzsche@mll.com
Vera Middelhauve
Head of business unit HR
Head of Human Resources
Head of Secretariat
vera.middelhauve@mll.com
Vera Middelhauve
Head of business unit HR
Head of Human Resources
Head of Secretariat
vera.middelhauve@mll.com
Nora Schmitt
HR Manager
Deputy Head of Human Resources
personalabteilung@mll.com
Prof. Dr. med. Wolfgang Kern
Executive Management
Internist, Hematologist and Oncologist
Head of business unit Finance
Head of business unit Strategy & Business Development
wolfgang.kern@mll.com
The company MLL
We are a leading institution for leukemia diagnostics and research, operating within a highly innovative environment. As a fast-growing international and interdisciplinary enterprise, we attach the highest importance to training our staff and developing our technological strategies. Our aim is to shape the future of hematological diagnostics and therapy through the use of state-of-the-art molecular and IT-supported methodologies.
MLL Münchner Leukämielabor GmbH was founded in 2005 by Prof. Dr. Dr. Torsten Haferlach, Prof. Dr. Claudia Haferlach, and Prof. Dr. Wolfgang Kern. MLL provides laboratory diagnostic services, specialized in leukemias and lymphomas, which are clinically reported together with MLL MVZ GmbH. MLL is constantly developing, both methodically in diagnostics and corporately. Thus, today further companies belong to MLL, which are regulated by cooperation agreements and partly managed in personnel union.
MLL MVZ GmbH was formed in 2021 by changing the name of MHP Münchner Hämatologiepraxis, which was founded in 2005. The MLL MVZ (Medical Care Center for Internal Medicine, Hematology and Internal Oncology) operates as a practice where 5000 patients are treated annually. In addition, the MLL MVZ provides laboratory services in cooperation with MLL Münchner Leukämielabor GmbH.
In 2017, MLL Dx GmbH was founded, which provides laboratory services for international patients and clinical studies.
Furthermore, MLL Dx GmbH hosts a sequencing service that became visible as its own label MLLSEQ since 2021. From wet-lab to data visualization, MLLSEQ offers its expertise and sequencing capabilities using Next Generation Sequencing.
MLLi GmbH was founded in 2017. It reflects innovation by name and deals with Big Data generated by high-throughput sequencing. MLLi provides physicians and scientists with bioinformatics tools to interpret sequencing data efficiently and state-of-the-art. MLLi uses, among other things, MLL's in-house variant database, which is currently the largest in the world in the field of hematological neoplasms.
Seminar rooms
Five conference rooms with sophisticated equipment, electrically dimmable glass partitioning walls, and a lecture theatre which can accommodate 190 guests, extend over a 500 m2 surface. When it came to furnishing the conference area, emphasis was placed on high quality and functionality – both in terms of interior design and in terms of the multimedia technology.
The premises are used for in-house trainings and meetings, as well as for conferences and congresses with external partners.
Should you be interested in renting these premises, please do not hesitate to contact us: Phone: +49 (0)89 99017-0, or via email at info@mll.com
Corporate movies
With our corporate movies you will gain exciting insights into the work and culture at MLL and what inspires and drives our employees day after day.
Corporate movie 2020
»See behind. Go beyond.«
English version
01:41
Corporate movie 2018
»See behind. Go beyond.«
English version
01:19
You may also be interested in
Your contact person
»Patient wellbeing and digitalization are not a contradiction, but the future.«
Prof. Dr. med. Dr. phil. Torsten Haferlach
Executive management
Internist, Hematologist and Oncologist
torsten.haferlach@mll.com